Advert: ACMPTFeb2010
line
Menu top
Menu bottom
Website and Archive search
  Go
JobSearch
  Go
  Advert: GoIndPfizerJan2010_300x250
MAGAZINE AUDIT BY
ABC Logo
Where am I? > Home
Hline
LATEST WORLD NEWS
Japan can become a big business for GSK – Witty
While the emerging markets such as Brazil, Russia, India and China are regularly mentioned as the best areas for growth, GlaxoSmithKline’s chief executive has put the spotlight on Japan as a land of rising sales

AstraZeneca signs 'cancer metabolism' pact with charity
AstraZeneca is teaming up with Cancer Research UK in a deal that will focus on “the emerging field of cancer metabolism”

Arrow More World News articles
Price rises "will drive US drug spend to $457.8 billion by 2019"
US prescription drug spending is estimated to have grown 5.2% to $246.3 billion in 2009, a two percentage point rise over 2008 which was due to increased per person usage of medicines and higher price growth for brand-name drugs, say new government figure.

Putin sacks Russian drugs law critic
Russian Prime Minister Vladimir Putin has sacked a senior health official for publicly criticising controversial new draft legislation to introduce state regulation of drug pricing.
LATEST JOBS
Arrow   Safety Physicians – all levels
Arrow   Senior Business Analyst
Arrow   Business Manager - Oncology
Arrow   G.P./Hospital Representative
Arrow   PRODUCT MANAGER - HOMECARE
Arrow   Pain Sales Specialist
Arrow   Senior Account Manager/Account Manager Flexible Remote Home Working/Office
Arrow   Client Service Executive
Arrow   BUSINESS DEVELOPMENT MANAGER - HOMECARE
Arrow   European Head of Business Development
Advert: ABPIJan2010PT
LATEST CLINICAL NEWS
Arrow PREDICT charter underlines trial bias against older people
Arrow FDA, PATH collaborate on pneumococcal vaccine technology
Arrow Data-sharing guidance addresses patient privacy risks
Arrow Roche setting up translational research hub in Singapore
Arrow More Clinical News articles
LATEST UK NEWS
Arrow BREAKING NEWS: GSK coy on job loss numbers as new restructuring hits R&D
Arrow Pfizer rolls out new generics portfolio in the UK
Arrow Dementia warning as costs spiral to £23 billion a year
Arrow The Lancet retracts Wakefield’s flawed MMR paper
Arrow More UK News articles
 
Join PharmaTimes Directors Club
Arrow Find out more
PharmaTimes Club for Directors Secretaries
Arrow Learn more
PHARMATIMES MAGAZINE FEATURE PHARMATIMES MAGAZINE FEATURE
The information highway
Peter Mansell explores the sometimes contentious relationship between journalism and the PR sector
Putting the patient at the centre
Relying on high-tech channels to achieve
success in patient programmes ignores one
fundamental point, says Adam Fleming
– the patient should be at the centre of your
planning
Arrow More articles
Arrow Subscribe
Arrow More articles
Arrow Subscribe
line
flickrtwitteryoutube